JNJ-49122944

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-49122944, covering 2015-01-30 to 2015-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male Participants [Phase 1]

See pricing